Analysts favor Aequs as the top IPO pick for long-term investors, citing its balance of growth, clarity, and valuation. While Meesho leads in unofficial market buzz with a higher GMP, Aequs offers tangible visibility to profitability within 12-24 months, making it a pragmatic choice for steady investors.